CANCER THERAPY USING A COMBINATION OF A HSP90 INHIBITORY COMPOUNDS AND A EGFR INHIBITOR
摘要
A pharmaceutical combination comprising an EGFR inhibitor and an Hsp90 inhibitor according to the following formulae (I) or (Ia) a tautomer, or a pharmaceutically acceptable salt thereof, wherein the variables in the structural formulae are defined herein. Also provided are methods for treating a proliferative disorder in a subject in need thereof using pharmaceutical combinations disclosed herein.
申请公布号
WO2011133520(A1)
申请公布日期
2011.10.27
申请号
WO2011US33008
申请日期
2011.04.19
申请人
SYNTA PHARMACEUTICALS CORP.;BLACKMAN, RONALD, K.;KEVIN, FOLEY, P.;PROIA, DAVID
发明人
BLACKMAN, RONALD, K.;KEVIN, FOLEY, P.;PROIA, DAVID